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I met Irwin Freedberg because of my 
position at the National Institutes of 
Health in Bethesda, Maryland, where 
I was executive secretary/scientific 
review administrator in the Division 
of Research Grants, later renamed the 
Center for Scientific Review. How did 
it come about that I, a former bench 
scientist from a far-off discipline, 
should be so lucky as to land amidst 
the investigative dermatologists and 
get to work — in review — with the 
likes of Irwin and his distinguished 
colleagues?
In 1946, after a wartime stint in the 
United States Navy, and under the 
good auspices of my undergraduate 
alma mater, Harvard College, I got a 
job as a chemical technician with the 
Massachusetts Department of Public 
Health. What impressed me particu-
larly in all of the hubbub was the 
quiet concentration of Walter Lever at 
Harvard Medical School, Department 
of Physical Chemistry. As he sat 
among the physical chemists in front 
of an array of upturned glass butter-
dish covers from which he harvested 
little skin-like fibrin precipitates to be 
deposited in porcelain wells for dry-
ing in a hot oven and ultimate weigh-
ing. My youthful conclusion from 
watching Dr. Lever was that research 
in dermatology did exist, it could be 
fun, and the boundaries of academic 
disciplines could be flexible. I liked 
the possibilities.
Fast-forward through graduate 
school, postdoc, and a decade of bio-
chemical research to 1961, when I 
joined the Division of Research Grants 
at the National Institutes of Health to 
review grant applications in biomedi-
cal research — first as executive sec-
retary of the Arthritis and Metabolic 
Diseases Program–Project Committee, 
and then conducting project-grant 
review with the General Medicine 
A Study Section. The latter became 
first GMA-1 and then the Arthritis, 
Connective Tissue and Skin Study 
Section, which reviews only grant 
proposals in dermatology and rheu-
matology. I had choices along the line, 
and they were inevitably to stay with 
review in dermatology. David Bickers 
must have noted this when he was 
chairing GMA-1, and he encouraged 
me to join the Society for Investigative 
Dermatology.
With all this bonding to dermato-
logy research and its community, it 
was inevitable that I would meet Irwin 
Freedberg. Irwin attended one meet-
ing of GMA-1 as an ad hoc member, 
and his performance was great. I tried 
to recruit him for full membership in 
GMA-1 but failed. Blame it on timing, 
his conflicting responsibilities, or what-
ever. Nevertheless, the channels stayed 
open, and we spoke often.
Irwin would always help when 
asked. His commitment to the review 
process at the National Institutes of 
Health was strong, and I appreciated 
being able to count on him.
Our last encounter was at a lun-
cheon in 2004 at the Society for 
Investigative Dermatology meeting 
in Providence, Rhode Island. Sitting 
next to him at the table, I had a fine 
opportunity to witness how he spar-
kled and interacted with the assem-
bled guests — lay, scientific, and aca-
demic — all of whom he seemed to 
know quite well.
Many people, myself included, miss 
him now.
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This is a thank you to Irwin M. Freedberg, 
MD, the exceptional senior editor 
of the two most recent editions of 
Fitzpatrick’s Dermatology in General 
Medicine (DIGM). He was the captain 
who steered the ship through smooth 
and also sometimes rough waters, 
expanding the book’s already stellar 
reputation. Dr Thomas B. Fitzpatrick, 
the founding editor, asked Irwin to 
join the second (1979) edition of 
DIGM as a Young Turk to bring fresh 
blood to a textbook already recog-
nized eight years after the first edition 
as one of the classics. Irwin served as 
senior editor of the fifth and sixth edi-
tions, published in 1999 and 2003, 
respectively. As he had done for the 
Journal of Investigative Dermatology 
in his role as editor (1972–1977), he 
brought DIGM to new heights.
Since its inception, DIGM had 
flourished as a textbook, with each 
subsequent edition bringing new 
editors, new authors, new areas of 
knowledge, and new techniques to the 
readership. However, Irwin stream-
lined the book, creating a concise, 
modern, and up-to-date work reflect-
ing the enormous span of dermatol-
ogy. Appropriately for its time, the first 
edition focused on medical dermatol-
ogy only, but it was later expanded 
to embrace pediatric dermatology, 
dermatopathology, and dermatologic 
surgery. Irwin championed this larger 
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scope and correctly believed that aes-
thetic concerns regarding the skin and 
its diseases should also be included 
to best serve students, practitioners, 
and, most importantly, patients. He 
also strengthened the DIGM “sig-
nature,” the integration of the basic 
and clinical sciences, by soliciting 
from contributors new approaches to 
the biology, structure, and function 
of the skin. Further, he introduced or 
expanded sections on evidence-based 
dermatology, skin changes over the 
lifespan, dermatologic therapy, der-
matologic surgery, and the emerg-
ing types of biologic therapy. At the 
same time, he reduced the roughly 
3,000 pages of the unwieldy fourth 
and fifth editions to 2,600 pages in the 
most recent sixth edition, upgraded 
the illustrative material that now is in 
full color throughout the book, and 
had all diagrams redrawn for ease of 
interpretation. Under Irwin’s leader-
ship, all the chapters on basic science 
were extensively rewritten to reflect 
the enormous advances made during 
the preceding decade. DIGM being a 
classic, Irwin advocated renaming it 
Fitzpatrick’s Dermatology in General 
Medicine to honor Dr Fitzpatrick, who 
had relinquished his role as a senior 
editor by the time of the fifth edition.
During production of the fifth and 
sixth editions, Irwin insisted on proof-
reading each chapter himself and 
reviewing the entire two-volume work 
to eliminate overlaps and redundan-
cies. He was a relentless worker, and 
only his wife Irene knows how much 
time and effort he invested in this 
project. In recognition of his vision 
and ongoing contributions, after Irwin 
relinquished his membership of the 
DIGM editorial board, his co-editors 
(Lowell A. Goldsmith, Stephen I. Katz, 
Barbara A. Gilchrest, Amy S. Paller, 
David J. Leffell, and myself) asked him 
to remain as an advisor for the seventh 
edition, now in preparation, and he 
admirably fulfilled this responsibility 
until his untimely death.
Irwin was a strong-handed edi-
tor whose authority was based on 
personal integrity as well as on the 
breadth and depth of his knowledge. 
A master of both clinical dermatol-
ogy and basic science, always abreast 
of recent developments in the field, 
he himself epitomized DIGM’s high 
standards. Irwin was also a compas-
sionate human being, unfailingly kind 
and understanding, with limitless and 
infectious enthusiasm and a unique 
sense of humor. These characteristics, 
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Irwin and I were fortunate to become 
physicians during the early years of 
the scientific revelations of the “new 
biology” that began to inform academ-
ic medicine. We both were medical 
house officers at Beth Israel Hospital 
in Boston during the latter days of 
Herman Blumgart’s reign as chair 
of medicine. Superb clinical medi-
cine prevailed with great emphasis 
on clinical–pathological correlation, 
infectious disease, and, most impor-
tantly, the observation, quantification, 
and manipulation of human physiol-
ogy. These pursuits were the bedrock 
of academic medicine. But Watson–
Crickery was in the air! At Beth Israel 
Hospital, Blumgart was succeeded by 
Howard Hiatt, recently returned from 
participating in the earliest days of the 
new biology at the Pasteur Institute. 
Hiatt brought a whole new vision of 
academic medicine. Irwin left Beth 
Israel Hospital during the Blumgart 
era to do his dermatology training at 
Massachusetts General Hospital and 
returned to join Hiatt in implementing 
a new paradigm of academic medi-
cine. I too left for my training and a 
junior faculty position at Yale. After I 
returned to Boston, both Irwin and I 
were engaged in building our respec-
tive academic programs in the clinic 
and the laboratory. Not only was Irwin 
building dermatology; under Hiatt’s 
leadership he, H. Richard Nesson, 
Howard Frazier, and others were 
remaking academic medicine at Beth 
Israel.
Irwin had spent the academic year 
1961–1962 as a postdoctoral fellow 
in the biochemistry department at 
Brandeis University and that of 1969–
1970 on a Guggenheim Fellowship 
at the Weizmann Institute in Israel. 
Both of these experiences equipped 
him with the tools of modern molec-
ular science. The titles of two papers 
authored by Irwin and published by 
the New England Journal of Medicine 
capture these two phases of his aca-
demic medical research. The first, 
published in 1957, “The thyroid gland 
in pregnancy,” was the kind of care-
ful observation and quantification of 
human physiology that was character-
istic of the academic medicine of the 
time. Irwin was the first author, and 
his coauthors were Milton Hamolsky 
(later to chair the Department of 
Medicine at Brown University) and 
Irwin’s uncle A. Stone Freedberg, a 
distinguished cardiologist interested in 
the relationship between thyroid func-
tion and the heart. The second paper, 
“Rashes and ribosomes,” authored 
only by Irwin and published just ten 
years later, offered promise of the 
practical relevance of basic molecular 
biology to clinical medicine.
in combination with high energy and 
a passion for perfection, explain the 
level of excellence he achieved. All 
that he accomplished, he did for his 
profession and for us, his extended 
dermatologic family.
Irwin, we will miss you.
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